Gadoteridol
 |
| Other names |
(10-(2-(hydroxy-κO)propyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3−)-κN1,κN4,κN7,κN10,κO1,κO4,κO7)-gadolinium |
|
AHFS/Drugs.com
|
Micromedex Detailed Consumer Information |
Routes of administration |
IV |
| ATC code |
|
| Legal status |
|
gadolinium(+3) cation; 2-[4-(2-hydroxypropyl)-7,10-bis(2-oxido-2-oxoethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate
|
| CAS Number |
|
|
PubChem CID
|
|
| DrugBank |
|
| ChemSpider |
|
| UNII |
|
| KEGG |
|
| ChEBI |
|
| ChEMBL |
|
|
CompTox Dashboard (EPA)
|
|
| Formula |
C17H29GdN4O7
|
| Molar mass |
558.69 g·mol−1
|
| 3D model (JSmol) |
|
[Gd+3].[O-]C(=O)CN1CCN(CCN(CCN(CC(O)C)CC1)CC([O-])=O)CC([O-])=O
|
InChI=1S/C17H32N4O7.Gd/c1-14(22)10-18-2-4-19(11-15(23)24)6-8-21(13-17(27)28)9-7-20(5-3-18)12-16(25)26;/h14,22H,2-13H2,1H3,(H,23,24)(H,25,26)(H,27,28);/q;+3/p-3 Y
Key:DPNNNPAKRZOSMO-UHFFFAOYSA-K Y
|
N Y (what is this?) (verify)
|
Gadoteridol (INN) is a gadolinium-based MRI contrast agent, used particularly in the imaging of the central nervous system. It is sold under the brand name ProHance.